Brand

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

Lilly's branded app for Trulicity looks to address adherence

Lilly's branded app for Trulicity looks to address adherence

By

Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.

The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study

The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study

By

In the United States, people over 50 are often stereotyped as complacent, set in their ways and extremely loyal to their preferred brands, but a new study released Tuesday by Ketchum found that the opposite is true.

Best Branded Website for Healthcare Professionals of 2016

Best Branded Website for Healthcare Professionals of 2016

By

CDM New York populated this engaging and outstanding website for Salix with unique visuals and messaging elements designed to drive awareness.

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.

Five things for pharma marketers to know: Wednesday, September 14, 2016

Five things for pharma marketers to know: Wednesday, September 14, 2016

By

Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

By

In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.

The co-pay card debate simmers, as payers push back

The co-pay card debate simmers, as payers push back

By

Will this payer pressure pose an existential threat to co-pay cards even though patients love them?

Five things for pharma marketers to know: Friday, July 15, 2016

Five things for pharma marketers to know: Friday, July 15, 2016

By

PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit

Can pharma movement campaigns flourish on both sides of the Atlantic?

Can pharma movement campaigns flourish on both sides of the Atlantic?

By

Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.

Cannes: The Heat Is On

Cannes: The Heat Is On

By

A rundown of MM&M at Cannes, and five burning questions heading into the Lions Health festival and awards.

Balancing Opportunity and Responsibility in Healthcare Targeting

Balancing Opportunity and Responsibility in Healthcare Targeting

If you truly understand who your high writers and compliant patients are, you'll understand when and how to communicate with prospects that look and act like them.

What Brand Won the Super Bowl of Pharma?

What Brand Won the Super Bowl of Pharma?

Pharma marketers are wondering if these exorbitant media buys ($4.9 million for 30 seconds) were worth the investment for Valeant and AstraZeneca. Was either strategy successful?

Urhekar, in biggest move yet as Americas president, unites McCann Health NA agencies

Urhekar, in biggest move yet as Americas president, unites McCann Health NA agencies

By

IPG's McCann Health announces branding and operational changes aimed at integrating its US and Canadian shops.

Five things for pharma marketers to know: November 11, 2015

Five things for pharma marketers to know: November 11, 2015

By

Dr. Reddy's is blocked from selling generic purple Nexium; the FDA approves Roche's melanoma drug; Novartis says Entresto keeps heart-failure patients from being readmitted to the hospital

An Open Letter: Allowing Regional Flexibility Bolsters Global Branding

An Open Letter: Allowing Regional Flexibility Bolsters Global Branding

We're not out to reinvent the wheel if we don't have to but we will need to localize the campaign for New Zealand and do what is right for our physicians and our patients.

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Pharma has hidden behind the ability to turn commenting off on Facebook pages, allowing marketers to use the channel much as they would a typical web page.

Mullen Lowe's Sokoloff closes Lions Health

By

The second annual Lions Health creativity festival ended Saturday.

A Q&A with Sir Roger Moore, 2015 Young Lions Health Award judge

A Q&A with Sir Roger Moore, 2015 Young Lions Health Award judge

By

Moore, a longtime Goodwill Ambassador for Unicef, talked with MM&M about how creativity can be used to improve public health.

Is Digital Marketing a Dead-End Job?

Is Digital Marketing a Dead-End Job?

Either we need to stop calling it digital marketing (because digital is baked into business) and just consider it marketing. If we feel like we can't, then digital might very well be a dead-end job.

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.

Merck's Heller on how to get more women into the C-suite

Merck's Heller on how to get more women into the C-suite

By

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.

Docs cozy up to brands that bring unique benefits, thought-leader backing

Docs cozy up to brands that bring unique benefits, thought-leader backing

By

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.

Hologic, seeking rights to Makena, trades barbs with KV

By

Hologic alleges KV has botched the marketing and wants rights to the drug. KV disagrees.

Herceptin treatment time scrutinized by researchers

By

A government-funded study looks at whether patients with breast cancer really need 12 months of the treatment.

Copaxone sales likely to top out this year, Teva exec says

By

Sales of Teva's MS blockbuster Copaxone are likely to peak this year before giving way as more therapeutic options become available, a Teva exec says.

Endo rebrands to move beyond roots in pain drugs

Endo rebrands to move beyond roots in pain drugs

By

Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs.

FDA gives guidance on brand, generic names in ads

By

The FDA issued guidance clarifying narrow questions of scientific or generic name placement in ads and labeling in different media, including electronic media.

As GSK jettisons consumer brands, smaller marketer sees boon

As GSK jettisons consumer brands, smaller marketer sees boon

By

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.

As brand revenue shrinks, so does brand promotion

By

Branded drug sales declined 0.7% to $229 billion last year, according to IMS Health, and that's having an impact on promotional spend.

OPINION

Email Newsletters